Please provide your email address to receive an email when new articles are posted on . Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases ...

If you have high cholesterol, there's a good chance your doctor has recommended statins to get your numbers back into a ...

NEW ORLEANS, LA—Ever since statin guidelines were revised to urge physicians to prescribe high-intensity statins rather than treating to a specific LDL target, the debate has continued: is the “fire ...

Two new studies published this week highlight the successes, as well as the disappointments, in the battle to get patients to take a high-intensity statin for secondary prevention. In the “good news” ...

Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were significantly more likely to be prescribed guideline-recommended high-intensity statin therapy ...

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to ...

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population. Last year, an HHS panel ...

The U.S. Preventive Services Task Force updated its 2016 recommendations for use of statins for primary prevention of clinical cardiovascular disease, according to an Aug. 23 statement on its website.